KALV   $11.4  1.97% Market Closed After Close 11.23 -1.49%

Kalvista Pharmaceuticals Inc
Total Cash 174.27M
totalCashPerShare 4.033
EBITDA -154.72M
Total Debt 6.25M
quickRatio 8.325
currentRatio 8.551
Total Revenue
debtToEquity 3.618
Revenue/Share
ROA -0.53937
ROE -0.90839
grossProfits
freeCashflow -57.84M
operatingCashflow -102.72M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 318.15M
forwardPE -6.101604
floatShares 26.08M
sharesOutstanding 43.22M
sharesShort 6.81M
sharesShortPriorMonth 5.72M
dateShortInterest
sharesPercentSharesOut 0.16%
heldPercentInsiders 0.01%
heldPercentInstitutions 1.23%
Short Ratio help_outline 13.35%
shortPercentOfFloat 0.18%
impliedSharesOutstanding
bookValue 4.011
Price To Book help_outline 2.84
earningsQuarterlyGrowth
netIncomeToCommon -141.77M
trailingEps -3.57%
forwardEps -1.87%
enterpriseToEbitda -2.06
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.91 4Q 2024
institutionsCount 170
lastUpdated Nov. 7, 2024, 2:33 a.m.